Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
British journal of haematology
Year: 2019, Volume: 184, Issue: 6, Pages: 1018-1021 |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.15204 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1111/bjh.15204 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15204 |
| Author Notes: | Oliver G. Ottmann, Carsten Müller‐Tidow, Alwin Krämer, Richard F. Schlenk, Michael Lübbert, Gesine Bug, Utz Krug, Tilmann Bochtler, Florian Voss, Tillmann Taube, Dan Liu, Pilar Garin‐Chesa, Hartmut Döhner |
| Item Description: | First published: 08 June 2018 Gesehen am 03.06.2019 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.15204 |